Prostatitis and chronic prostatitis/chronic pelvic pain syndrome

Area of Science:

• Urology
• Andrology
• Infectious Diseases

Background:

• Prostatitis affects up to 16% of men, with multifactorial etiology and evolving treatment strategies.
• Chronic prostatitis and chronic pelvic pain syndrome represent significant clinical challenges.
• Recent years have seen significant alterations in standard treatment regimens for prostatitis.

Purpose of the Study:

• To review changing scientific perspectives on the etiology and treatment of prostatitis.
• To examine infectious and noninfectious causes and the role of antimicrobial therapy.
• To discuss current NIH classifications, diagnostic tools, and multimodal treatment approaches.

Main Methods:

• Literature review of scientific views on prostatitis etiology and treatment.
• Analysis of infectious and noninfectious causes and antimicrobial efficacy.
• Discussion of NIH classifications, NIH Chronic Prostatitis Symptom Index, diagnostic tests, and multimodal therapies.

Main Results:

• Etiology of prostatitis is multifactorial, necessitating updated treatment approaches.
• Antimicrobial treatment plays a role in infection eradication and symptom amelioration.
• Current research focuses on diagnostic refinements (e.g., two-glass test) and multimodal therapies including biofeedback and pelvic floor dysfunction.

Conclusions:

• Understanding of prostatitis etiology and treatment is continuously evolving.
• Multimodal treatment strategies, addressing factors like pelvic floor dysfunction, are crucial.
• Further research is needed to optimize diagnosis and management of prostatitis and chronic pelvic pain syndrome.